Janus Henderson Group PLC Pacific Biosciences Of California, Inc. Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
A detailed history of Janus Henderson Group PLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 109,941 shares of PACB stock, worth $201,192. This represents 0.0% of its overall portfolio holdings.
Number of Shares
109,941
Previous 111,324
1.24%
Holding current value
$201,192
Previous $417,000
64.03%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding PACB
# of Institutions
258Shares Held
234MCall Options Held
1.02MPut Options Held
965K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.2MShares$60.8 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA26MShares$47.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$43.2 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA23.4MShares$42.8 Million5.63% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V816.7MShares$30.6 Million0.4% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $411M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...